Table 3 Comparison of data from testing phase and follow-up phase of 38 patients with NB who underwent SNM permanent electrode implantation.
Parameters | Testing phase | Follow-up phase | t/Z | P |
|---|---|---|---|---|
Voiding times | 8.2 ± 1.8 | 7.0 ± 1.2 | 4.039 | < 0.001 |
Average voiding volume (mL) | 169.2 ± 92.3 | 211.9 ± 89.0 | − 4.062 | < 0.001 |
Daily catheterization frequency | 6.8 ± 2.4 | 6.6 ± 1.6 | 0.738 | 0.469 |
Daily catheterization volume (mL) | 171.0 [120.8, 225.0] | 115.0 [36.8, 178.0] | − 3.88 | 0.001 |
Functional bladder capacity (mL) | 218.5 ± 107.7 | 283.3 ± 98.3 | − 4.884 | < 0.001 |
Quality of life score | 4.7 ± 2.7 | 2.6 ± 1.8 | 7.795 | < 0.001 |
OABSS score | 2.0 [1.0, 3.0] | 1.0 [1.0, 2.0] | − 3.421 | 0.001 |
Bowel dysfunction score | 5.2 ± 4.0 | 3.7 ± 3.1 | 2.843 | 0.015 |
Maximum urine flow rate (mL/s) | 9.8 ± 6.1 | 13.5 ± 7.7 | − 3.852 | 0.001 |
Postvoid residual volumes (mL) | 195.0 [107.5, 312.5] | 105.0 [47.5, 242.5] | − 3.414 | < 0.001 |
Maximum detrusor pressure before voiding (cmH2O) | 24.2 ± 10.9 | 16.2 ± 7.8 | 5.179 | < 0.001 |
Bladder compliance (mL/cmH2O) | 16.3 ± 11.8 | 25.4 ± 11.4 | − 5.635 | < 0.001 |
Maximum cystometric capacity (mL) | 275.8 ± 63.4 | 325.1 ± 62.3 | − 5.759 | < 0.001 |
